May 22, 2025 RDCA-DAP and NORD’s IAMRARE Platform to Platform Federation: Lessons Learned Patient data is a key asset in understanding the progression of rare diseases....
April 9, 2025-April 10, 2025 2025 Clinical Outcome Assessment Program Annual Meeting Recap On April 9-10, 2025, the 2025 Clinical Outcome Assessment...
April 11, 2025 C-Path Launches Newest Podcast Episode: Connecting the Dots Between T1D and Parkinson’s In our latest episode of the C-Path podcast, “Connecting the Dots Between Type 1 Diabetes and Parkinson’s Disease,” we...
April 2, 2025 C-Path’s Stephenson Appears on Xtalks’ Life Science Podcast to Talk Future of Drug Development in Parkinson’s, Alzheimer’s C-Path's Diane Stephenson recently appeared on the Xtalks Life Science Podcast...
March 27, 2025 From Musician to Physician to Clinical Scientist: C-Path CEO Klaus Romero Shares His Journey During National Physicians Week Every year, National Physicians Week is celebrated from March 25-31, a time to honor the dedication and resilience of our...
March 25, 2025 Breaking Down Research: Investigation of Urinary miRNAs for Early Detection of Kidney Damage in selected lab animals Drug-induced kidney injury is commonly identified during drug development and serves as a dose-limiting factor...
March 24, 2025 Lysosomal Storage Disease Data Sharing Workshop, Webinar Series Session #2: Case Studies #1 – Proactive Data Sharing This webinar from Critical Path Institute's Critical Path to Lysosomal Diseases Consortium presents...
The Critical Path Institute Podcast: Connecting the Dots with COA VP Dr. Cheryl Coon If you have attended one of C-Path’s stakeholder meetings, read one of our impact stories or engaged through our social...
March 21, 2025 Wrangling Real-World Data: Optimizing Clinical Research Through Factor Selection with LASSO Regression Data-driven approaches to clinical research are necessary for understanding and effectively treating infectious diseases.
April 17, 2025 ACE Inhibitors as a Cardioprotective Treatment in Dystrophinopathies ACE inhibitors were the first pharmacological class shown to benefit heart failure treatment...
